News for March 2010

News Archive

Movies for the human genome Movies for the human genome

Name a human gene, and you can find a movie online showing you what happens to cells when it is switched off.

Nerve growth factor could boost painkiller market Nerve growth factor could boost painkiller market

Nerve-growth-factor-targeting drugs could restore confidence in the pain relief field, boosting the market and enabling the development of novel painkillers.

Vantia Therapeutics reveals dysmenorrhoea treatment structure Vantia Therapeutics reveals dysmenorrhoea treatment structure

Vantia Therapeutics announced recently that it had revealed the structure of oral small-molecule drug candidate VA111913, a potential new treatment for dysmenorrhoea, for the first time.

Cross-species study on colorectal cancer published Cross-species study on colorectal cancer published

A team of scientists has pinpointed genes likely to be responsible for colorectal cancer by identifying genomic copy number abnormalities that are common in both canine and human colorectal cancer research samples.

Nobel Prize winner James Black dies

Sir James Whyte Black, the Scottish scientist who was awarded the Nobel Prize for Medicine for the invention of propranolol, has died at the age of 85 after a long illness.

DNA sequencing pioneer is BBSRC Innovator of the Year DNA sequencing pioneer is BBSRC Innovator of the Year

Professor Shankar Balasubramanian has been named as the BBSRC Innovator of the Year 2010, winning £10,000 in recognition of his work on Solexa sequencing, a high-speed genome sequencing technology.

Deuterium Depletion: a new concept in anticancer drug development Deuterium Depletion: a new concept in anticancer drug development

The 1st International Symposium on Deuterium Depletion will be held on 13–14 May 2010 in Budapest, Hungary, and will enable researchers and medical practitioners to get acquainted with deuterium depletion, a novel tool of submolecular medicine.

Omega-3 preparation protects against bowel polyps Omega-3 preparation protects against bowel polyps

A new preparation of an omega-3 polyunsaturated fatty acid found naturally in fish could offer hope for thousands of patients at risk of developing an inherited form of bowel cancer.

Sigma-Aldrich to acquire Ace Animals Sigma-Aldrich to acquire Ace Animals

The acquisition will enhance SAGE Labs’ rodent husbandry capabilities, add new models to their product portfolio and add a strategic location for US animal distribution.

Competition intensifying for transdermal pain products Competition intensifying for transdermal pain products

The convergence of active lifestyles, aging joints and a more enlightened approach by practitioners to treating pain is contributing to an attractive demand picture for pain management drug products.

Cellzome in €500m GlaxoSmithKline deal Cellzome in €500m GlaxoSmithKline deal

Cellzome announces second major strategic drug discovery alliance with GlaxoSmithKline in inflammatory disease.

Online amyotropic lateral sclerosis (ALS) resource launched Online amyotropic lateral sclerosis (ALS) resource launched

Trophos, announcing the launch of MitoTarget Online on behalf of the MitoTarget consortium, hopes the site will support patients and carers and speed up finding a cure for ALS, which has attacked many people – including scientist Stephen Hawking.

Enterprise hub foundations laid at Colworth Science Park Enterprise hub foundations laid at Colworth Science Park

Construction work is underway on The Exchange, a new enterprise hub at Colworth Science Park that is being developed by Unilever and Goodman.

New UK facility for Thermo Fisher Scientific New UK facility for Thermo Fisher Scientific

The new facility, located in Runcorn, Cheshire, is a substantial investment for Thermo Fisher Scientific in the north of England and is a new designated Center of Excellence for its Anatomical Pathology business.

Shire supports Rare Disease Day 2010 Shire supports Rare Disease Day 2010

Shire announced today it will actively support Rare Disease Day across the world by generating media coverage in many countries to raise awareness and understanding of rare diseases.